Kodein ExtractumPharma: Uses, Dosage & Side Effects

What Is Kodein ExtractumPharma and What Is It Used For?

Kodein ExtractumPharma contains codeine phosphate as its active ingredient, available in 10 mg tablets. Codeine is a naturally occurring opiate alkaloid found in the opium poppy plant (Papaver somniferum), first isolated in 1832 by the French chemist Pierre Jean Robiquet. It belongs to the class of medications known as opioid analgesics and is one of the most widely used opioids worldwide. The World Health Organization (WHO) includes codeine on its Model List of Essential Medicines, recognizing its importance in managing pain and cough when used appropriately.

Codeine functions primarily as a prodrug, meaning it must be metabolized in the body to produce its main pharmacological effects. After oral ingestion, codeine is absorbed from the gastrointestinal tract and transported to the liver, where it undergoes biotransformation through several enzymatic pathways. The most clinically significant pathway involves the cytochrome P450 enzyme CYP2D6, which converts approximately 5–15% of the administered codeine dose into morphine. It is this conversion to morphine that is primarily responsible for codeine’s analgesic (pain-relieving) properties. Codeine is also metabolized by CYP3A4 to norcodeine (an essentially inactive metabolite) and undergoes glucuronidation to codeine-6-glucuronide, which may contribute modestly to its analgesic effect.

The analgesic action of codeine (via its active metabolite morphine) occurs through binding to mu-opioid receptors in the central nervous system (CNS). These receptors are distributed throughout the brain and spinal cord, particularly in regions involved in pain perception and emotional response to pain, including the periaqueductal gray matter, rostral ventromedial medulla, and the dorsal horn of the spinal cord. Activation of mu-opioid receptors inhibits ascending pain pathways, alters the perception of pain at the cortical level, and produces emotional detachment from pain stimuli. This dual action on both the sensory and affective components of pain makes codeine effective for mild to moderate pain conditions.

As an antitussive, codeine acts on the cough center located in the medulla oblongata of the brainstem. By suppressing the cough reflex at this central level, codeine reduces the frequency and intensity of non-productive (dry) coughing. This effect occurs at doses lower than those typically required for analgesia. It is important to note that codeine should not be used to suppress productive cough (cough that produces mucus), as the cough reflex serves a protective function in clearing the airways. The antitussive effect of codeine is well-established, though systematic reviews have questioned the magnitude of benefit over placebo for acute cough associated with upper respiratory tract infections.

Kodein ExtractumPharma is indicated for two primary clinical uses. For pain management, it is prescribed for the short-term relief of mild to moderate pain that is not adequately controlled by non-opioid analgesics such as paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs (NSAIDs) alone. According to the WHO analgesic ladder, codeine occupies Step 2 (mild opioid), positioned between non-opioid analgesics (Step 1) and strong opioids such as morphine (Step 3). Codeine is commonly used for conditions such as postoperative dental pain, musculoskeletal pain, headache, and dysmenorrhea. For cough suppression, it is used for the short-term symptomatic treatment of dry, irritating, non-productive cough in adults, particularly when the cough interferes with sleep or daily activities.

What Should You Know Before Taking Kodein ExtractumPharma?

Contraindications

There are several absolute contraindications to the use of codeine that must be carefully considered before initiating treatment. Codeine must not be taken by individuals with a known hypersensitivity (allergy) to codeine phosphate or any other opioid. Allergic reactions to opioids, while uncommon, can include urticaria, angioedema, bronchospasm, and in rare cases, anaphylaxis.

Codeine is strictly contraindicated in children under 12 years of age for any indication. This restriction was implemented by the European Medicines Agency (EMA) in 2013 and the U.S. Food and Drug Administration (FDA) in 2017 following reports of serious adverse events, including deaths, in children who were CYP2D6 ultra-rapid metabolizers and received codeine after tonsillectomy. For adolescents aged 12–18 years, codeine should only be used for pain when other analgesics are insufficient and must not be used for cough and cold. It is also contraindicated in all patients under 18 years following tonsillectomy or adenoidectomy for obstructive sleep apnea syndrome.

Codeine must not be used in patients with respiratory depression, including acute severe asthma, chronic obstructive pulmonary disease (COPD) exacerbations, or any condition where respiratory function is already compromised. It should not be used in patients with paralytic ileus, acute alcoholism, raised intracranial pressure, or head injury. Codeine is contraindicated in patients who are known or suspected CYP2D6 ultra-rapid metabolizers.

Warnings and Precautions

Codeine carries significant warnings that all patients and prescribers must be aware of. The most serious risk associated with codeine use is respiratory depression, which can be fatal. This risk is heightened in elderly or debilitated patients, those with pre-existing respiratory conditions, patients receiving concurrent CNS depressants, and individuals who are CYP2D6 ultra-rapid metabolizers. Respiratory depression is more likely to occur at higher doses, during dose escalation, or when codeine is combined with other respiratory depressants.

Physical and psychological dependence can develop with regular use of codeine, even at therapeutic doses and even after relatively short treatment periods. Tolerance (the need for progressively higher doses to achieve the same effect) may also develop. Abrupt discontinuation after prolonged use can lead to withdrawal symptoms including restlessness, lacrimation, rhinorrhea, yawning, sweating, chills, myalgia, and mydriasis. Patients should be instructed to use codeine for the shortest duration necessary and at the lowest effective dose. If codeine has been taken regularly for more than a few days, it should be tapered gradually rather than stopped abruptly.

Patients with hepatic impairment require dose adjustment or avoidance of codeine, as the liver is the primary site of codeine metabolism. Reduced hepatic function can lead to decreased conversion to morphine (potentially reducing efficacy) but also to delayed clearance of codeine and its metabolites, prolonging the duration of effects and increasing the risk of accumulation. Similarly, patients with renal impairment may experience prolonged effects due to reduced excretion of codeine metabolites, including morphine-6-glucuronide, an active metabolite that can accumulate in renal failure and cause toxicity.

Elderly patients are more susceptible to the effects of codeine due to age-related changes in pharmacokinetics (reduced hepatic and renal function, altered body composition) and pharmacodynamics (increased sensitivity to CNS depressants). Lower starting doses and careful monitoring are recommended. Codeine can cause postural hypotension, which is particularly dangerous in elderly patients at risk of falls.

Pregnancy and Breastfeeding

Codeine should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus. Animal studies and epidemiological data suggest that opioid use during early pregnancy may be associated with an increased risk of certain birth defects, although the evidence is not conclusive for codeine specifically. Regular use of codeine during the third trimester can lead to neonatal opioid withdrawal syndrome (NOWS), a condition characterized by irritability, excessive crying, tremors, feeding difficulties, diarrhea, and in severe cases, seizures in the newborn. Neonates exposed to opioids in utero should be monitored carefully after birth.

Codeine is strictly contraindicated during breastfeeding. The EMA and FDA both recommend against the use of codeine in breastfeeding mothers. Codeine and its active metabolite morphine pass into breast milk. In mothers who are CYP2D6 ultra-rapid metabolizers, dangerously high levels of morphine can be present in breast milk, posing a risk of life-threatening respiratory depression and sedation in the nursing infant. A case of neonatal death attributed to morphine toxicity from breast milk was reported in 2006 in a breastfeeding mother who was a CYP2D6 ultra-rapid metabolizer taking codeine at standard doses.

How Does Kodein ExtractumPharma Interact with Other Drugs?

Drug interactions with codeine can be broadly categorized into pharmacodynamic interactions (where the combined effect of two drugs is altered) and pharmacokinetic interactions (where one drug affects the absorption, distribution, metabolism, or excretion of another). Understanding these interactions is critical because several combinations can be life-threatening. Patients should always inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting codeine therapy.

Major Interactions

The most dangerous interactions involve the combination of codeine with other central nervous system (CNS) depressants. When codeine is taken together with alcohol, benzodiazepines (such as diazepam, alprazolam, or lorazepam), other opioid analgesics, sedative antihistamines, barbiturates, general anesthetics, or other sedative drugs, the depressant effects on the brain and respiratory system are additive or even synergistic. This can lead to profound sedation, severe respiratory depression, coma, and death. The concurrent use of opioids and benzodiazepines has been identified by the FDA, EMA, and numerous public health agencies as a major contributor to opioid-related overdose deaths.

Monoamine oxidase (MAO) inhibitors, including both irreversible (phenelzine, tranylcypromine) and reversible (moclobemide) types, interact with codeine in a potentially life-threatening manner. MAO inhibitors can potentiate the effects of opioids, leading to severe CNS depression, hypotension, and serotonin syndrome. Codeine should not be taken within 14 days of discontinuing an irreversible MAO inhibitor.

Concurrent use of codeine with serotonergic drugs (including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, triptans, and St. John’s Wort) may increase the risk of serotonin syndrome, a potentially life-threatening condition characterized by altered mental status, neuromuscular hyperactivity, and autonomic instability.

Pharmacokinetic Interactions

CYP2D6 inhibitors are particularly important because they reduce the conversion of codeine to morphine, thereby diminishing its analgesic and antitussive effectiveness. Common CYP2D6 inhibitors include the SSRI antidepressants fluoxetine and paroxetine, the antiarrhythmic quinidine, the antihistamine diphenhydramine, and the antimycotic terbinafine. Patients taking these medications may find that codeine provides little or no pain relief. In such cases, alternative analgesics should be considered rather than increasing the codeine dose.

CYP3A4 inhibitors (such as ketoconazole, itraconazole, erythromycin, clarithromycin, and ritonavir) can increase codeine plasma levels by inhibiting its metabolism to norcodeine, potentially leading to increased opioid effects including sedation and respiratory depression. CYP3A4 inducers (such as rifampicin, carbamazepine, and phenytoin) can decrease codeine plasma levels, potentially reducing efficacy.

What Is the Correct Dosage of Kodein ExtractumPharma?

Dosing of codeine must be individualized based on the severity of the pain or cough, the patient’s age, weight, overall health status, previous opioid experience, and response to treatment. The goal is always to use the lowest effective dose for the shortest duration necessary to manage symptoms. The tablets should be swallowed whole with a glass of water and may be taken with or without food, although taking them with food may help reduce nausea.

Adults

Children and Adolescents

Codeine is contraindicated in children under 12 years of age for all indications. For adolescents aged 12–18 years, codeine may be used for pain relief only when other analgesics (paracetamol, ibuprofen) are insufficient, at a dose of 15–30 mg every 4–6 hours as needed (maximum 240 mg/day). Codeine is contraindicated in all patients under 18 years for cough and cold treatment, and in those under 18 years following tonsillectomy or adenoidectomy for obstructive sleep apnea.

Elderly Patients

Elderly patients generally require lower doses of codeine due to age-related changes in metabolism, increased sensitivity to opioid effects, and higher prevalence of comorbidities. A reduced starting dose (e.g., 10–15 mg every 6 hours) is recommended, with careful titration based on response and tolerability. Close monitoring for excessive sedation, confusion, respiratory depression, constipation, and falls is essential. Renal and hepatic function should be assessed before initiating treatment.

Missed Dose

If you miss a dose of Kodein ExtractumPharma, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Since codeine is typically used “as needed” for pain or cough rather than on a fixed schedule, missed doses are generally not a concern. The goal is to use the medication only when symptoms require it, at the lowest effective dose.

Overdose

What Are the Side Effects of Kodein ExtractumPharma?

Like all medications, codeine can cause side effects, although not everyone experiences them. The frequency and severity of side effects are generally dose-dependent, meaning that higher doses and longer treatment durations are associated with more frequent and more severe adverse reactions. Most common side effects are mild and may improve as the body adjusts to the medication. However, some side effects can be serious and require immediate medical attention.

The side effects of codeine are related to its opioid mechanism of action and affect multiple organ systems. Gastrointestinal effects are among the most common, with constipation being particularly prevalent because opioids reduce intestinal motility. Unlike many other opioid side effects, tolerance to constipation develops slowly or not at all, meaning that patients taking codeine regularly will likely need prophylactic measures such as increased fluid and fiber intake or a laxative. CNS effects (drowsiness, dizziness) are also very common, especially at the beginning of treatment, and can impair the ability to drive or operate machinery.

Below is a comprehensive summary of codeine side effects organized by frequency, based on data from clinical trials, post-marketing surveillance, and published medical literature.

How Should You Store Kodein ExtractumPharma?

Proper storage of codeine-containing medications is important both for maintaining the medication’s effectiveness and for safety reasons. Kodein ExtractumPharma tablets should be stored at room temperature, not exceeding 25°C (77°F). The tablets should be kept in their original packaging to protect them from light and moisture, as exposure to these elements can degrade the active ingredient over time. Do not store the medication in the bathroom, near a sink, or in any area with high humidity.

Because codeine is a controlled substance with potential for misuse and addiction, secure storage is essential. Keep the medication in a locked location or in a place that is not easily accessible to others, particularly children, adolescents, and anyone with a history of substance use disorder. Accidental ingestion of even a single dose of codeine by a child can result in serious harm, including fatal respiratory depression.

Do not use Kodein ExtractumPharma after the expiry date printed on the package. Expired opioid medications should not be kept in the home. To dispose of unused or expired codeine tablets, use a medicine take-back program if available in your area. If no take-back program is available, consult your pharmacist about proper disposal. Do not flush codeine tablets down the toilet or throw them in household waste unless specifically instructed to do so by local disposal guidelines, as improper disposal can contribute to environmental contamination and accidental exposure.

What Does Kodein ExtractumPharma Contain?

The active ingredient in Kodein ExtractumPharma is codeine phosphate hemihydrate, equivalent to 10 mg of codeine phosphate per tablet. Codeine phosphate is the phosphate salt form of codeine, chosen for its improved water solubility and stability compared to codeine base, which facilitates consistent absorption from the gastrointestinal tract after oral administration.

In addition to the active ingredient, each tablet contains pharmaceutical excipients (inactive ingredients) that serve various functions in the manufacturing process and in the tablet’s physical characteristics. Common excipients used in codeine phosphate tablets include lactose monohydrate (filler/diluent), maize starch or pregelatinized starch (binder/disintegrant), microcrystalline cellulose (filler), magnesium stearate (lubricant), and talc (glidant). Patients with known lactose intolerance or allergies to any excipient should review the full list of ingredients provided in the product leaflet and consult their pharmacist or doctor before taking the medication.

The tablets are typically small, round, and white or off-white in appearance, and are designed for oral administration. They may have a break-line (scored line) to facilitate dose adjustment, although the ability to split the tablet accurately may vary. Codeine phosphate is a white, crystalline powder with a slightly bitter taste. The molecular formula of codeine phosphate hemihydrate is C₁₈H₂₁NO₃·H₃PO₄·½H₂O, with a molecular weight of approximately 406.4 g/mol.